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Abstract
TOP2A and TOP2B are type II topoisomerase enzymes that have important but distinct roles in DNA replication
and RNA transcription. Recently, TOP2B has been implicated in the transcription of long genes in particular
that play crucial roles in neural development and are susceptible to mutations contributing to
neurodevelopmental conditions such as autism and schizophrenia. This study maps their expression in the early
foetal human telencephalon between 9 and 12 post-conceptional weeks. TOP2A immunoreactivity was
restricted to cell nuclei of the proliferative layers of the cortex and ganglionic eminences (GE), including the
ventricular zone and subventricular zone (SVZ) closely matching expression of the proliferation marker KI67.
Comparison with sections immunolabelled for NKX2.1, a medial GE (MGE) marker, and PAX6, a cortical
progenitor cell and lateral GE (LGE) marker, revealed that TOP2A-expressing cells were more abundant in MGE
than the LGE. In the cortex, TOP2B is expressed in cell nuclei in both proliferative (SVZ) and post-mitotic
compartments (intermediate zone and cortical plate) as revealed by comparison with immunostaining for PAX6
and the post-mitotic neuron marker TBR1. However, co-expression with KI67 was rare. In the GE, TOP2B was
also expressed by proliferative and post-mitotic compartments. In situ hybridisation studies confirmed these
patterns of expression, except that TOP2A mRNA is restricted to cells in the G2/M phase of division. Thus,
during early development, TOP2A is likely to have a role in cell proliferation, whereas TOP2B is expressed in
post-mitotic cells and may be important in controlling expression of long genes even at this early stage.
Key words: autism susceptibility genes; cortical development; DNA replication; ganglionic eminences; RNA
transcription.
Introduction
The helical structure and supercoiling of DNA is essential
for nuclear packaging; however, processes such as DNA
replication and transcription require complete separation
and partial separation of the strands, respectively. During
transcription, the partial separation of the DNA allows RNA
polymerase and transcription factors to access specific gene
regions, creating tension in the DNA. Topoisomerase
enzymes govern the topological state of DNA in both
prokaryotic and eukaryotic cells, allowing unwinding of the
DNA and relieving the torsional strain created by supercoil-
ing (Nitiss, 2009a). Cells have type I and II topoisomerase
enzymes. Type I topoisomerases (TOP1 and TOP3) are able
to break a single strand of DNA, allowing the intact strand
to pass through it before re-joining the broken strand,
whilst type II topoisomerases (TOP2) carry out ATP-
mediated strand breakage of one or both strands. Human
topoisomerases comprise distinct alpha and beta isoforms
(Austin & Marsh, 1998). Topoisomerase poisons are effective
anti-cancer drugs as they prevent cell replication and induce
apoptosis (Nitiss, 2009b).
In rodents, expression of Top2a and Top2b in the brain is
higher during early embryogenesis compared with the later
stages (Capranico et al. 1992). However, there is a surge of
Top2b expression in the brain of newborn mice that is not
observed for Top2a or the marker of cell proliferation
thymidylate synthase. Top2a expression is most apparent
in proliferating tissues whereas Top2b expression is not
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confined to regions of proliferation, suggesting a role for
rodent Top2b outside of DNA replication (Capranico et al.
1992; Tsutsui et al. 1993; Watanabe et al. 1994). Top2b is
the predominantly expressed topoisomerase enzyme in
mouse neurons (Tiwari et al. 2012), and has been shown to
play a role in the development and lamination of the neo-
cortex (Yang et al. 2000; Lyu & Wang, 2003). By E16.5,
Top2b protein is found in the proliferative regions of the
ventricular zone (VZ) and the subventricular zone (SVZ) of
the mouse neocortex as well as in the post-mitotic regions
of the cortical plate (CP), subplate (SP) and marginal zone
(MZ). Homozygous mutants exhibit abnormal cortical
organisation at E16.5 with the SP being absent and the VZ
appearing thickened compared with wild type (WT) (Lyu &
Wang, 2003). As these defects appear late in development
and expression is seen in areas containing differentiated
neurons, again this suggests a role for Top2b outside of
DNA replication. Table 1 provides a summary of what is
known about expression, localisation and function of type
2 isomerases in mouse and rat.
TOP2B has been implicated in transcriptional regulation
in human cell lines (Ju et al. 2006; Perillo et al. 2008; Haff-
ner et al. 2010; McNamara et al. 2010; Thakurela et al.
2013; Isik et al. 2015), and topoisomerases are known to be
expressed in the developing and adult human brain (Zand-
vliet et al. 1996; Plaschkes et al. 2005). Evidence suggests
that topoisomerase mutations can potentially affect the
expression of susceptibility genes of neurodevelopmental
disorders, including autism spectrum disorder (ASD; King
et al. 2013) Fragile X syndrome (Xu et al. 2013) and mental
retardation (Tarsitano et al. 2014). It has been shown that
TOP2B may be required for efficient transcription of a sub-
set of long genes linked to ASD with roles in synapse forma-
tion and stabilisation (King et al. 2013). This raises the
possibility that topoisomerase proteins may have develop-
mental roles in establishing the neural circuitry essential for
the proper functioning of the human brain.
This study focusses on the expression of TOP2A and
TOP2B in the developing human brain as they are highly
expressed in neuronal cells. For the first time, the spatial
expression of TOP2A and TOP2B was looked at across the
developing human telencephalon from 9 to 12 post-con-
ceptional weeks (PCW) using histochemical techniques.
This time period covers the end of embryogenesis and the
onset of the foetal stages, from the beginning of the for-
mation of the CP but before thalamic afferents have
innervated the cerebral cortex. In order to interpret these
expression patterns more easily, nearby sections were
immunostained for proteins that have been validated as
markers for known human cell types/compartments
(Bayatti et al. 2008a; Pauly et al. 2014), including PAX6
(radial glia), KI67 (dividing cells), TBR1 (early post-mitotic
cortical neurons) and NKX2.1 [progenitor cells of the med-
ial ganglionic eminence (MGE)].
Table 1 Topoisomerase 2 nervous system expression, localisation and function in animal models.
Mouse Rat
Top2a Top2b Top2a Top2b
Development Mainly expressed in
proliferative tissues
(Capranico et al. 1992)
Expressed in both
proliferating and non-
proliferative tissues
(Capranico et al. 1992)
Transcripts highly expressed in
embryonic brain but
undetectable 4 weeks after
birth (Tsutsui et al. 1993)
Transcripts present
throughout embryonic
and postnatal stages
(Tsutsui et al. 1993)
An absence of Top2b
affects cerebral
stratification as well as
causing a lack of axon
innervation in skeletal
muscles and spinal cord
(Yang et al. 2000; Lyu &
Wang, 2003)
In the developing cerebellum,
Top2a expression is confined
to proliferative layer (Tsutsui
et al. 1993)
In the developing
cerebellum, Top2b
expression is seen
throughout cortical
region (Tsutsui et al.
1993)
There is a shift from Top2a
to Top2b expression
during neuronal
differentiation (Tiwari
et al. 2012)
Expressed in the VZ of
embryonic brains (E13–15)
(Watanabe et al. 1994)
Expressed throughout the
brain from E13 to P21
(Watanabe et al. 1994)
Maturity Low expression in adult
brain tissue relative to
other tissues (Capranico
et al. 1992)
High expression in adult
brain relative to other
tissues (Capranico et al.
1992)
VZ, ventricular zone.
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Materials and methods
Human tissue
Human embryonic and foetal brain sections between 8 and 12 PCW
were obtained from the MRC-Wellcome Trust Human Developmen-
tal Biology Resource (HDBR, http://www.hdbr.org). Brains were col-
lected from terminations of pregnancy with maternal consent with
the approval of local ethical committees. Age was determined by
the assessment of external morphology (O’Rahilly et al. 1987; Bullen
& Wilson, 1997) or by comparing foot and heel to knee length with
a standard growth chart (Hern, 1984).
Immunohistochemistry (IHC)
Brains were fixed in buffered 4% paraformaldehyde solution (PFA;
Sigma Aldrich, Dorset, UK) and embedded in paraffin wax before
sectioning. Deparaffinised coronal and sagittal sections collected on
slides were immersed in 1.5% hydrogen peroxide : methanol solu-
tion (Sigma Aldrich) to block activity of endogenous peroxidases.
Heat-mediated antigen retrieval was carried out by treatment of
sections in citrate buffer (pH 6.0) before incubating sections with
10% of the appropriate normal serum (Vector Laboratories, Peter-
borough, UK) in Tris-buffered saline (TBS) for 10 min. For
immunoperoxidase staining, sections were then incubated with a
primary antibody (Tables 2 and 3 for source of antibodies and
dilutions used) in TBS solution overnight at 4 °C. Sections were then
washed and incubated for 30 min with the appropriate biotinylated
secondary antibody (Vector Laboratories), washed then incubated
for 30 min with Vectastain Elite ABC kit (Vector Laboratories) and
developed using 3,30-diaminobenzidine (Vector Laboratories). Sec-
tions were dehydrated, cleared and coverslipped.
For immunofluorescent double-labelling, a novel procedure that
allows two polyclonal primary antibodies to be employed was
developed from the methods of Goto et al. (2015). Sections were
incubated with the first primary antibody as before, washed and
incubated with ImmPRESSTM HRP IgG (Peroxidase) Polymer Detec-
tion Kit, made in horse (IF; Vector Laboratories), washed then incu-
bated for 30 min with tyramide signal amplification (TSATM)
fluorescein plus system reagent (IF; Perkin Elmer, London, UK). After
washing but before application of a second primary antibody, heat-
mediated antigen retrieval was carried out by treatment of sections
in citrate buffer (pH 6.0). This removes the first set of primary and
secondary antibodies employed, but leaves fluorescent tyramide
covalently bound to the tissue section. The method above was
repeated for the detection of this second primary antibody, except
that tyramide signal amplification (TSATM) rhodamine plus was used
for detection. Sections were then washed, stained with 40,6-diami-
dino-2-phenylindole, dihydrochloride (DAPI; Thermo Fisher Scien-
tific), washed and coverslipped with Vectashield (Vector
Laboratories).
Manufacture of in situ hybridisation (ISH) probes
Polymerase chain reaction (PCR) using specific primers (Sigma
Aldrich; Table 4) amplified the required DNA fragment of the gene
of interest using human brain foetal DNA as a template, which was
run on a gel to confirm the correct size of the product. The band
was gel extracted (Qiagen, Crawley, UK), and the DNA was cloned
and transformed into competent cells using the pGEM-T Easy kit
(Promega, Southampton, UK). Select colonies were grown in 5 mL
LB-Broth (Invitrogen, Paisley, UK) with ampicillin (overnight). Plas-
mids were prepared using the Miniprep kit (Qiagen) and the HiS-
peed plasmid Maxiprep kit (Qiagen) before restriction digest using
the Qiagen PCR purification kit. Digoxigenin-UTP was incorporated
into riboprobes during in vitro transcription using the DIG RNA
Labelling Kit (SP6/T7; Roche, Indianapolis, USA) according to the
manufacturer’s instructions. Antisense and sense probes were gen-
erated using T7 and SP6 polymerase, respectively. Probe concentra-
tion was measured (Nanodrop; Thermo Scientific, Waltham, USA).
Table 2 Primary and secondary antibodies used in this study.
Primary
antibody Species Dilution Supplier
KI67 Mouse 1/150 Dako, Cambridgeshire,
UK, clone MIB1
NKX2.1 Mouse 1/150 Dako, Cambridgeshire,
UK
PAX6 Rabbit polyclonal 1/1500 Covance, Cambridge
Bioscience, UK
TBR1 Rabbit polyclonal 1/1500 Abcam, Cambridge, UK
TOP2A Rabbit polyclonal 1/800 Prof. Caroline Austin*
TOP2B Rabbit polyclonal 1/800 Prof. Caroline Austin*
*From research funded by Leukaemia and Lymphoma Research.
Table 3 Immunogen sequences detected by polyclonal rabbit antibodies raised against TOP2A and TOP2B.
Gene Immunogen sequence Length/aa
TOP2A EGSPQEDGVELEGLKQRLEKKQKREPGTKTKKQTTLAFKPIKKGKKRNPWSDSESDRSSDESNFDVP
PRETEPRRAATKTKFTMDLDSDEDFSDFDEKTDDEDFVPSDASPPKTKTSPKLSNKELKPQKSVVSD
LEADDVKGSVPLSSSPPATHFPDETEITNPVPKKNVTVKKTAAKSQSSTSTTGAKKRAAPKGTKRDP
ALNSGVSQKPDPAKTKNRRKRKPSTSDDSDSNFEKIVSKAVTSKKSKGESDDFHMDFDSAVAPRAK
SVRAKKPIKYLEESDEDDLF
287
TOP2B LDTAAVKVEFDEEFSGAPVEGAGEEALTPSVPINKGPKPKREKKEPGTRVRKTPTSSGKPSAKKVKKR
NPWSDDESKSESDLEETEPVVIPRDSLLRRAAAERPKYTFDFSEEEDDDADDDDDDNNDLEELKVK
ASPITNDGEDEFVPSDGLDKDEYTFSPGKSKATPEKSLHDKKSQDFGNLFSFPSYSQKSEDDSAKFDS
NEEDSASVFSPSFGLKQTDKVPSKTVAAKKGKPSSDTVPKPKRAPKQKKVVEAVNSDSDSEFGIPKK
TTTPKGKGRGAKKRKASGSENEGDYNPGRKTSKTTSKKPKKTSFDQDSDVDIFPSDFPTEPPSLPRT
GRARKEVKYFAESDEEEDDVDF
358
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Tissue in situ hybridisation (TISH)
Paraffin sections were dewaxed in two changes of histoclear and
gradually hydrated in decreasing ethanol concentrations. Sections
were washed twice in PBS fixed for 20 min in PFA. Sections were
washed twice in PBS and then incubated with proteinase K (20
lL mL1; Sigma Aldrich) for 8 min and post-fixed in 4% PFA : PBS
(Sigma) at room temperature for 5 min. After two washes in PBS,
sections were treated with 0.1 M tetraethylammonium/0.25% acetic
anhydride for 10 min, washed again twice in PBS. Dehydrated and
air-dried slides were covered with 300 ng DIG-labelled riboprobe,
hybridisation mix (50% formamide, 0.3 M NaCl, 20 mM Tris pH 8.5, 5
mM EDTA pH 8.0, 19 Denharts solution, 10% dextran sulphate),
tRNA (0.5 mg mL1) and RNAse inhibitor (1 lL mL1), coverslipped
and the mixture was incubated overnight at 65 °C to allow hybridis-
ation of probes to the tissue mRNA. Post-hybridisation washes were
performed [29 standard sodium citrate (SSC), 65 °C; 0.29 SSC,
65 °C; 29 formamide wash (350 mL formamide, 70 mL 209 SSC,
280 mL dH2O)], and slides were incubated for 1 h in 150 mM NaCl
and 100 mM Tris–HCl, pH 7.5, containing 10% foetal calf serum
followed by incubation with anti-DIG : alkaline phosphatase and
expression was visualised using NBT/BCIP (Roche), sections mounted
using Vectamount (Vector Laboratories).
Imaging
Images were taken using an Axioimager Z2 microscope equipped
with an Axiocam and Axioimager Z2 4.8.1 software or scanned
using the Leica SCN400 Slide Scanner. Final images for publication
were produced using Adobe Photoshop CS6 software.
Results
TOP2A is expressed in regions of cell division
TOP2A protein localisation was determined using antibod-
ies that recognise the C-terminal domain of the protein
(Fig. 1A), residues 1244–1531 (Table 2). The transcription
factor PAX6 is involved in cortico-neurogenesis and
Table 4 Primers used to manufacture probes used in the detection of TOP2A, TOP2B and TBR1 mRNA sequences.
Gene Forward primer 50–30 sequence Reverse primer 50–30 sequence Product size/bp
TBR1 TAAGTTAATACGACTCACTATAGGGCGA AATACGATTTAGGTGACACTA TAGAATAC 426
TOP2A GCCCAAGACTGGTTTTAAAGTT TGGAGATTTCCCAAAATGAATC 800
TOP2B TTGGTCAGATGATGAATCCAAG AAGACGGTTTTCCCTTTTTAGC 500
Fig. 1 Schematic of TOP2A and B protein
and mRNA showing the regions detected/
amplified by IHC and ISH techniques.
Polyclonal antibodies designed to recognise
the C-terminal domain of the TOP2A and
TOP2B proteins were designed (A). Probes
were manufactured to identify the 30 UTR of
TOP2A within exon 34 and a region spanning
exons 30–34 near the end of the coding
sequence for TOP2B (B). Control probes were
designed for the same regions to identify any
antisense transcripts or non-specific staining.
© 2015 The Authors. Journal of Anatomy published by John Wiley & Sons Ltd on behalf of Anatomical Society.
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expressed in the radial glial progenitor cells found in the VZ
and SVZ of the developing human cerebral cortex (Bayatti
et al. 2008a,b; Lui et al. 2011; Fig. 2). TOP2A immunoreac-
tivity was detected in these proliferative regions at 9, 11
and 12 PCW (Fig. 2), although fewer cells were TOP2A-posi-
tive than PAX6-positive, suggesting that TOP2A protein is
not found in all radial glial progenitor cells. Instead, the
staining was more comparable to that of the marker of cell
division KI67 (Scholzen & Gerdes, 2000; Fig. 2). TOP2A and
KI67 both appeared very strongly at the apical surface of
the VZ (Fig. 2), where cells are in the G2/M phase of division
(Scholzen & Gerdes, 2000). Both markers also densely
labelled cells in the inner subventricular zone (ISVZ; Fig. 2),
where TBR2-expressing intermediate progenitor cells are
located (Bayatti et al. 2008a; Lui et al. 2011). A few cells of
the intermediate zone (IZ) also stained positively for TOP2A
at 9 PCW; however, as the IZ expands and becomes a more
prominent feature of the cerebral cortex, fewer TOP2A-
immunopositive cells could be found (Fig. 2). The prolifera-
tive VZ and SVZ decreased in relative size as the cortex aged
from 9 to 12 PCW due to the expansion of the post-mitotic
layers.
To explore the extent of co-localisation more precisely,
double-label immunofluorescence was attempted with a
novel method that allowed the use of two primary antibod-
ies from the same species and gave more sensitivity with
paraffin sections than using conventional fluorescently con-
jugated secondary antibodies. It was possible to demon-
strate that TOP2A was indeed co-expressed with Ki-67
(Fig. 3A), whereas not all PAX6-positive radial glial cells
were TOP2A-positive (Fig. 3C), only those found at locations
where KI67 was expressed, principally the apical surface of
the VZ, and the ISVZ. As predicted, cells that express the
post-mitotic marker TBR1 did not express TOP2A (Fig. 3E).
TBR1 expression was restricted to the CP, IZ and some cells
of the SVZ. TBR1 was not expressed in the VZ and cells that
expressed TBR1 in the SVZ did not co-express TOP2A.
TOP2B is expressed in both proliferative and post-
mitotic regions of the cortex
TOP2B protein localisation was determined using antibodies
that recognise the C-terminal domain of the protein
(Fig. 1A), residues 1263–1621 (Table 1). TOP2B, in contrast
to TOP2A, was observed throughout the cortex in layers
occupied by both PAX6-positive proliferative radial glia and
TBR1-positive post-mitotic neurons (Englund et al. 2005;
Bedogni et al. 2010; Fig. 2). At 9 PCW, TOP2B immunostain-
ing was stronger in the SVZ and the CP than in the VZ, as
was the case for TBR1 immunoreactivity (Fig. 2). At 9 PCW,
the ventricular surface was immunopositive for TOP2B
(Fig. 2) as it was for TOP2A, suggesting again that cells in
the G2/M phase of cell division might express TOP2B as well
as TOP2A. This is as expected as both TOP2B and TOP2A are
expressed in undifferentiated cells (Thakurela et al. 2013).
By 11 PCW (Fig. 2), staining was uniform throughout the VZ
and was no longer stronger at the ventricular surface. Dou-
ble-labelling at 11 PCW showed that cells expressing KI67
did not express TOP2B (Fig. 3B). TOP2B was expressed in
cells throughout the VZ and SVZ; however, these cells were
not KI67-positive. In comparison to this, some of the cells at
the apical VZ and inner SVZ did express both TOP2A and
TOP2B (Fig. 3D). This showed that not all of the cells
expressing KI67 were immunopositive for TOP2A. Instead,
there was a small proportion of TOP2A cells that may have
ceased to express KI67 and have begun to co-express TOP2A
and TOP2B.
TBR1 expression was restricted to the CP, IZ and some
cells of the SVZ. TBR1 was not expressed in the VZ and
cells that express TBR1 in the SVZ did not co-express
TOP2A (Fig. 3E). Although devoid of TOP2A expression,
the post-mitotic CP was immunopositive for TOP2B from
9 to 12 PCW. Cells in this region have ceased division
and have begun to differentiate into neurons. Fluores-
cent double-labelling using TBR1 and TOP2B (Fig. 3F)
confirmed that cells of the CP and IZ co-expressed these
markers. A closer look at the cells of the CP reveals that
cells that co-express both TBR1 and TOP2B were concen-
trated in the outer layers of the CP where younger cells
have just finished radial migration from the proliferative
zones (Rakic, 2009), whereas layers that contain the most
mature neurons, the inner layer of the CP, as well as the
SP and MZ, contained many cells that were only TBR1-
positive (Fig. 3F). Only a limited number of cells in this
region were both TBR1 and TOP2B immunofluorescent.
The majority of cells in the IZ expressed both TBR1 and
TOP2B, and these may be radially migrating neuroblasts
(Fig. 3F). A proportion of cells in the CP only expressed
TOP2B, and these may be interneurons that do not
express TBR1 as they are born in the GE (Hansen et al.
2013) but do express TOP2B (see below) and migrate
tangentially to the CP (Hansen et al. 2013). There were a
limited number of cells within the IZ and SVZ that
expressed only TOP2B as is the case in the cells of the
VZ (Fig. 3G). The presence of TOP2B and not TOP2A in
the CP suggests a separate role for TOP2B in the post-
mitotic cortical cells of the developing cerebral cortex;
however, TOP2B appears to be downregulated as the
neurons mature.
TOP2A is more prominent in the MGE than in the
lateral ganglionic eminence (LGE)
The cells of the GE can be split into distinct populations
known as the LGE, MGE and caudal ganglionic eminence
regions, all of which contain a high proportion of prolifera-
tive cells (Del Bigio, 2011). The location of the MGE was
revealed by NKX2.1 immunoreactivity (Fig. 4A), whilst PAX6
immunoreactivity extended from the proliferative zones of
the ventral pallium of the cortex into the LGE (Fig. 4B) but
© 2015 The Authors. Journal of Anatomy published by John Wiley & Sons Ltd on behalf of Anatomical Society.
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Fig. 2 Immunoperoxidase staining for TOP2A and TOP2B in the human cerebral cortex. PAX6 transcription factor immunoreactivity identified the
ventricular zone (VZ) and subventricular zone (SVZ) of the human cerebral cortex from 9 to 12 PCW. TOP2A immunoreactivity was confined to the
proliferative ventricular and subventricular regions at 9, 11 and 12 PCW (A–C), and was similar in distribution to immunoreactivity for the cell divi-
sion marker, KI67. Both were more prevalent in the inner than outer subventricular zone (ISVZ and OSVZ) that emerge by 11 PCW, unlike PAX6,
which is unformly expressed throughout the SVZ. From 9 to 12 PCW, TOP2B immunoreactivity was present in the VZ and SVZ, as well as the inter-
mediate zone (IZ), subplate (SP), post-mitotic cortical plate (CP) and cell sparse marginal zone (MZ), all of which were also immunopositive for the
transcription factor TBR1 (A–C). Scale bar: 250 lm.
© 2015 The Authors. Journal of Anatomy published by John Wiley & Sons Ltd on behalf of Anatomical Society.
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decreased in expression in a lateral to medial gradient. Both
KI67 (Fig. 4C) and TOP2A (Fig. 4D) immunoreactivity were
observed in the MGE and LGE; however, the immunoreac-
tivity was less dense at the LGE : MGE boundary (arrow-
head) compared with the density of cells shown by the H&E
stain (Fig. 5). TOP2B immunoreactivity was observed
throughout the MGE and LGE with no boundary apparent
(Fig. 4E). TOP2A immunopositivity appeared to be stronger
in the MGE (Fig. 4D) in comparison to TOP2B, which
appeared to be stronger in the LGE (Fig. 4E). The emerging
caudate nucleus, which contains post-mitotic cells migrating
away from the proliferative zones of the GE, showed high
levels of TOP2B expression, but not TOP2A expression
(Fig. 4D,E).
TOP2A and TOP2B mRNA expressed at the apical
surface of the VZ, and TOP2B expressed throughout
the cortex
At 12 PCW, TBR1 mRNA was located in the post-mitotic
cells of the CP (Fig. 6A). This corresponded with TBR1 pro-
tein localisation (Figs 2 and 3). TOP2A mRNA was
restricted to the apical surface of the VZ as well as a
small number of cells scattered throughout the VZ
(Fig. 6C). This differed slightly from TOP2A protein locali-
sation as the protein was found throughout the VZ and
SVZ (Fig. 2). This suggests that TOP2A mRNA has a much
shorter half-life than the protein and that its expression is
tightly controlled. TOP2B mRNA was detected throughout
A B C D
E F G
Fig. 3 Immunofluorescent double-labelling for TOP2A,TOP2B and other markers in the human cerebral cortex. (A–E) Taken from an 11 PCW foe-
tus, (F, G) from 12 PCW. (A) Extensive co-expression (pale green, yellow and orange cells) of TOP2A (red) and KI67 (green) immunofluorescence,
whereas (B) demonstrates that there was very little co-expression of TOP2B and KI67 as red and green cells predominate. (C) Not all PAX6-expres-
sing cells co-expressed TOP2A, but those that did clustered close to the apical surface of the ventricular zone (VZ) and the border of the ventricular
and subventricular zones (white arrows). Cells co-expressing TOP2A and TOP2B also preferred these locations (D). (E) TOP2A and TBR1 show sepa-
ration of expression although with a mingling of cells in the SVZ. On the other hand, (F) shows that TBR1 was co-expressed with TOP2B in many
cells in the cortical plate (CP), intermediate zone (IZ) and subventricular zone (SVZ; G), although cells expressing only TOP2A were observed
throughout the CP and cells expressing TBR1 only were frequently seen in the deeper layers of the CP, marginal zone (MZ) and subplate (SP). Scale
bars: 100 lm (in A for A–D, E, and in F for F and G).
© 2015 The Authors. Journal of Anatomy published by John Wiley & Sons Ltd on behalf of Anatomical Society.
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the cortex at 12 PCW in both proliferative and post-mito-
tic regions (Fig. 6E). This matched the protein expression
of TOP2B (Fig. 2).
Discussion
It was found that TOP2A and TOP2B mRNA and protein are
expressed in the VZ and SVZ of both the pallium and sub-
pallium of the human telencephalon between 9 and 12
PCW. In addition, TOP2B was also expressed in post-mitotic
cells of the telencephalon, suggesting it may have a role in
transcription in immature human neurons.
Expression in the proliferative zones of the pallium
The precise localisation of TOP2A expression and the differ-
ences between protein and mRNA give clues to the nature
of cell proliferation in human pallial proliferative zones. Far
fewer cells expressed TOP2A than PAX6, the marker for
radial glial progenitors, which is the major population of
progenitor cells at this stage of primate cortical develop-
ment (Lui et al. 2011; Betizeau et al. 2013). However, the
majority of cells that express TOP2A also express KI67,
the cell division marker that is expressed throughout all
the phases of the cell cycle (Scholzen & Gerdes, 2000).
A
D E
B C
Fig. 4 TOP2A and TOP2B immunoreactivity in the ganglionic eminences (GE). NKX2.1 immunopositivity (A) was predominantly observed in the
medial ganglionic eminence (MGE), whilst PAX6 immunoreactivity (B) marked the lateral ganglionic eminence (LGE). The dividing cells in both the
MGE and LGE were immunopositive for KI67 (C), TOP2A (D) and TOP2B (E). The medial part of the LGE showed a reduction in KI67, PAX6 and
TOP2A immunoreactivity. TOP2B immunopositivity was also observed in the caudate and putamen (E), whereas TOP2A was absent from these
post-mitotic regions (D). (D and E) contain high-magnification views of the transition between proliferative and post-mitotic cell layers. Scale
bar: 1 mm in low-magnification images; 75 lm in high-magnification insets.
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TOP2A mRNA was, however, more restricted in expres-
sion, suggesting that its half-life is much less than the pro-
tein and is restricted to the G2/M phase, as it is seen
predominantly in cells near to the apical surface of the VZ.
During asymmetric division of apical radial glial cells, the
nucleus undergoes interkinetic nuclear migration, shuttling
between the basal boundary of the VZ and the apical (ven-
tricular) surface in phase with the cell cycle, and is critical
for self-renewal of neural progenitor cells (Kosodo et al.
2004; Taverna & Huttner, 2010). TOP2A expression is known
to increase throughout the S phase and peak during the
G2/M phase, before being rapidly degraded during G1
(Heck et al. 1988; Woessner et al. 1991; Negri et al. 1992).
Interestingly, although TOP2A and KI67 immunoreactiv-
ity were observed in the SVZ, and likely to be localised to
dividing basal radial glia and intermediate progenitor cells
(Lui et al. 2011; Betizeau et al. 2013), very little TOP2A
mRNA expression was seen in this compartment. Perhaps cell
division occurs less frequently in the SVZ or, alternatively,
this reflects a difference in the dynamics of cell division once
progenitors lose their apical process and cease to undergo
interkinetic nuclear migration (Taverna & Huttner, 2010).
Cells of the VZ and SVZ showed either KI67 or TOP2B
expression, suggesting that TOP2B is not involved in cell
division. TOP2B also appears to be redundant during this
process in human cell lines (Grue et al. 1998) and neurogen-
esis is normal in Top2b knockout mice (Yang et al. 2000).
There are, however, cells that co-express TOP2A and TOP2B
in these proliferative regions suggesting that, as cells begin
to differentiate, there is an overlap in type II topoisomerase
Fig. 5 Haematoxylin and eosin (H&E) staining of a coronal section through the human telencephalon at 12 PCW. The ventricular zone (VZ) and
subventricular zone (SVZ) of the cerebral cortex and the lateral and medial ganglionic eminences (LGE and MGE) contain proliferative cells. In the
cortex, cells migrate from the VZ and SVZ, through the intermediate zone (IZ), to reach the post-mitotic cortical plate (CP). The caudate, putamen
and globus pallidus are regions containing post-mitotic cells derived from the ganglionic eminences (GE). Scale bar: 1 mm in low-magnification
image; 200 lm in high-magnification insert.
Fig. 6 TOP2A and TOP2B mRNA expression in the cortex at 12 PCW. TBR1 mRNA was detected in the cortical plate (CP) of the cerebral cortex at
12 PCW, and was absent from the intermediate zone (IZ) and ventricular zone (VZ) (A). TOP2A mRNA was detected at the apical surface of the VZ
(C) and in a small proportion of cells scattered throughout the VZ (C). TOP2B mRNA was detected throughout the cortex in both the proliferative
VZ and subventricular zone (SVZ), the IZ and the post-mitotic CP (E). Control experiments with sense transcripts to TBR1 (B), TOP2A (D) and TOP2B
(F) showed no staining of the cortex at 12 PCW. Scale bar: 250 lm.
© 2015 The Authors. Journal of Anatomy published by John Wiley & Sons Ltd on behalf of Anatomical Society.
TOP2A/2B expression in foetal human forebrain, L. F. Harkin et al. 9
expression during the transition from DNA replication to
RNA transcription. Top2b is expressed by post-mitotic neu-
rons (Capranico et al. 1992; Tsutsui et al. 1993; Tiwari et al.
2012). Co-expression of TOP2B with the post-mitotic marker
TBR1 in the human SVZ has been demonstrated. It is known
that many cells in the human SVZ express several post-
mitotic neuronal markers, such as TBR1, MAP2 and CTIP2
(Bayatti et al. 2008a; Ip et al. 2011), and therefore the
increased expression of TOP2B in the SVZ may reflect this.
Expression in the subpallium
A complicated pattern of expression of TOP2A was
observed across the subpallial compartments, but this most
likely matches the extent to which cell division is taking
place at each location, as it matches the pattern of KI67
expression. Reduced TOP2A expression at the medial
boundary of the LGE coincides with a reduced density of
dividing cells and PAX6-positive radial glia. However, this
does not prove a requirement for PAX6-expressing radial
glia in order to observe dividing cells as TOP2A expression is
high in the MGE in the absence of PAX6. The MGE is the
developmental source of pallidal projection neurons, stri-
atal interneurons and about 50% of cortical inhibitory
interneurons in the human (Marin et al. 2000; Xu et al.
2008; Hernandez-Miranda et al. 2010; Hansen et al. 2013;
Wang et al. 2013). Neural stem cells (VZ) and intermediate
progenitors (SVZ) of the MGE instead express NKX2.1, and
the SVZ of the MGE is expanded in size and complexity in
primate compared with the rodent, presumably to provide
increased numbers of interneurons to populate the relative
larger cerebral cortex of primate species (Hansen et al.
2013). The high levels of TOP2A expression in this compart-
ment may reflect this increased level of cortical interneuron
progenitor activity.
TOP2B expression in post-mitotic neurons
As in rodents, TOP2B mRNA and protein is found in the
post-mitotic CP where no DNA synthesis is taking place, con-
sistent with the suggestion that it regulates gene expression
concerned with cell differentiation and survival (Thakurela
et al. 2013). Cells that co-express TOP2B and TBR1 are more
apparent in the superficial layers of the CP, which are
formed from the cells that have most recently migrated
here from the proliferative regions, past the deep layer neu-
rons (Rakic, 2009). This suggests that cells may lose TOP2B
expression as they mature. At later stages of mouse devel-
opment, both TOP2A and TOP2B expression in the brain
decreases (Capranico et al. 1992).
Top2b knockdown is known to disrupt target finding of
axons (Yang et al. 2000), and produce shorter neurite
lengths and growth cone degeneration (Nur-E-Kamal et al.
2007). Top2b has been proposed as the main regulator of
ganglion cell axon path-finding during zebrafish retinal
development (Nevin et al. 2011). Mouse retina-specific
Top2b knockout alters expression of a number of genes
concerned with both cell survival and differentiation, and
results in aberrant lamination of the retina as well as loss of
synaptic connections in the inner and outer plexiform lay-
ers, and the degeneration of neurofilaments. Interestingly,
neurexin genes 1 and 3, which code for cell adhesion mole-
cules implicated in synapse formation and stabilisation, are
significantly downregulated (Li et al. 2014). These genes
have been identified as risk alleles for ASDs in human (Feng
et al. 2006; Szatmari et al. 2007; Yan et al. 2008; Vaags
et al. 2012; Dachtler et al. 2014). Inhibition or knockdown
of Top2b in cultured murine neurons decreased the expres-
sion of a very similar set of genes greater than 67 kb in size
many of which, in humans, are susceptibility genes for ASD
and involved in synaptic adhesion and synapse formation,
including NRXNs 1 and 3 (King et al. 2013). These NRXNS,
along with other susceptibility genes such as CNTNAP2 and
RELN included in the gene set, are known from microarray,
qPCR, RNAseq and histological studies to be expressed in
post-mitotic compartments of the early human foetal cortex
(Meyer et al. 2000; Abrahams et al. 2007; Ip et al. 2010;
Kang et al. 2011; Konopka et al. 2012), suggesting ASD sus-
ceptibility genes may have roles in early developmental
events such as cell migration and axon outgrowth, as well
as late events such as synapse formation and stabilisation.
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